Friday 6 November 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.

Revenue: −0.43%
EPS: −7.98%
Free cash flow: +20.0%
Total debt: +1.55%

Quarter to September 2026, against a year earlier

29.96 0.83 −2.70%

Follow PFE

Alert me

Market cap: $170.3B
P/E: 42.2×
Fwd P/E: 18.9×
Dividend yield: 7.18%
F-score: 6/9
Altman Z: 2.03
Beneish M: −2.52
Dividend safety: 28/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Pfizer Inc. (PFE) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Pfizer Inc. (PFE) trades at a P/S ratio of 2.7×. Over the past ten years it has ranged from 2.0× (April 2025) to 7.4× (December 2020); the current reading is higher than 29% of that period. That is below the Drug Manufacturers General industry median of 3.5× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PFE/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Pfizer Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PFE/metrics/ps-ratio">Pfizer Inc. (PFE) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	2.3×	(4.26%)
FY2024	2.4×	(16.17%)
FY2023	2.8×	(0.85%)
FY2022	2.8×	(30.17%)
FY2021	4.1×	(17.12%)
FY2020	4.9×	(5.85%)
FY2019	5.2×	(15.04%)
FY2018	6.1×	51.65%
FY2017	4.0×	8.83%
FY2016	3.7×	(3.97%)

Period	P/S ratio	Change
Sep 2026	2.6×	18.59%
Jun 2026	2.2×	(14.64%)
Mar 2026	2.5×	11.62%
Dec 2025	2.3×	(1.99%)
43 more quarters	Free account

Against its own ten years

Low 2.0× High 7.4×

Ten-year median 3.8×

Current reading's percentile 32

Company	P/S ratio
SNY Sanofi compare	1.9×
GSK GSK PLC Sponsored ADR compare	2.2×
BMY Bristol Myers Squibb Company compare	2.6×
PFE Pfizer Inc.	2.7×
NVO Novo Nordisk A/S compare	3.5×
AZN AstraZeneca PLC compare	4.7×
NVS Novartis AG compare	5.4×
AMGN Amgen Inc. compare	6.4×
GILD Gilead Sciences, Inc. compare	6.7×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Pfizer Inc. (PFE) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on PFE

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on PFE

Stockrow Weekly